These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


100 related items for PubMed ID: 5198294

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Relapse of tuberculosis in relation to previous treatment.
    Sellergren TL.
    Scand J Respir Dis Suppl; 1970; 72():76-82. PubMed ID: 5273225
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Evaluation of the treatment with reserve drugs of patients excreting drug resistant bacilli, as one solution to the problem of the so-called "chronic cases"].
    Pieniazek J, Martyniak-Murczkiewicz Z, Schnotale J, Waligóra-Antczak R.
    Gruzlica; 1968 Oct; 36(10):1050-2. PubMed ID: 5710087
    [No Abstract] [Full Text] [Related]

  • 27. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
    Ramarokoto H, Andrianasolo D, Rasolonavalona T, Ramaroson F, Razafitsiarovana I, Vincent V, Ratsimba L, Rasolofo Razanamparany V.
    Arch Inst Pasteur Madagascar; 2003 Oct; 69(1-2):37-40. PubMed ID: 15678814
    [Abstract] [Full Text] [Related]

  • 28. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs].
    Mauro G.
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):461-6. PubMed ID: 5309059
    [No Abstract] [Full Text] [Related]

  • 29. [Chemotherapy in patients with chronic pulmonary tuberculosis].
    Bernard E.
    Tuberkuloza; 1966 Jun; 18(1-3):11-5. PubMed ID: 16296060
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Clinical experiences with the new antitubercular agent Myambutol].
    Kilic S.
    Med Klin; 1968 Dec 20; 63(51):2082-5. PubMed ID: 5730449
    [No Abstract] [Full Text] [Related]

  • 35. [On the efficacy of treating pulmonary tuberculosis with various combinations of first-series chemical preparations].
    Kochnova IE, Mikhaĭlova GN, Pashchenko NI, Chelnokova AK, Selivanova TL.
    Sov Med; 1967 Sep 20; 30(9):45-50. PubMed ID: 5604647
    [No Abstract] [Full Text] [Related]

  • 36. [Problems caused by circumscribed caseous pulmonary tuberculosis in the antitubercular dispensary].
    Bucur D, Szima Z.
    Ftiziologia; 1971 Sep 20; 20(6):615-8. PubMed ID: 5162287
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Ethambutol, capreomycin and rifampicin in lung tuberculosis].
    Hellström PE, Repo UK.
    Nord Med; 1968 Dec 19; 79(51):1723-9. PubMed ID: 5712754
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.